Published in
American Society for Microbiology, Microbiology Spectrum, 2(10), 2022
DOI: 10.1128/spectrum.02107-21
Links
Tools
Performance of dRAST on Prospective Clinical Blood Culture Samples in a Simulated Clinical Setting and on Multidrug-Resistant Bacteria
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
There is an utmost need for rapid antimicrobial susceptibility testing (AST) of bacteria causing bloodstream infections (BSI). The dRAST (QuantaMatrix Inc., Seoul) is a rapid AST method that can be performed directly from positive blood cultures.